Table 2. Serum lipid analysis of low-density lipoprotein receptor-knockout (LDLr KO) mice fed a HFD with treatment of pravastatin or pravastatin plus sarpogrelate.
Milligrams/deciliter | NFD | HFD | HFD + PRA 40 mg/kg | HFD + PRA 40 mg/kg + SAR 50 mg/kg |
---|---|---|---|---|
Total cholesterol | 351.1 ± 17.67 | 2132 ± 111.1 | 1353 ± 104.3 *** | 1446 ± 84.13 *** |
Triglycerides | 113.3 ± 11.94 | 1048 ± 195.1 | 232.0 ± 33.29 *** | 377.1 ± 18.00 ** |
HDL cholesterol | 100.7 ± 3.496 | 87.25 ± 5.593 | 89.50 ± 2.693 | 84.50 ± 3.813 |
LDL cholesterol | 111.1 ± 7.818 | 787.5 ± 40.64 | 512.5 ± 32.14 ** | 542.3 ± 34.37 ** |
Data represented as mean ± standard error and significance was analyzed by Student’s t-test (**,*** denote significant difference to HFD group, **P < 0.01, ***P < 0.001, n = 7–8/group).
Abbreviations: NFD, normal fat diet; HFD, high fat diet; SAR, sarpogrelate; PRA, pravastatin